Hidden Multibagger Stocks by Devendra (RA: INH000026488)

"Sai life science " is outperforming even in a falling market, which indicates that institutional investors and other large market participants are accumulating pharma stocks. This reflects growing confidence in the pharma sector's earnings outlook...🚀

"Laurus Labs " is outperforming even in a falling market, which indicates that institutional investors and other large market participants are accumulating pharma stocks. This reflects growing confidence in the pharma sector's earnings outlook...🚀

💥Market Outlook: Why Patience Is the Key in the Current Market💥 I Predicted Today's Market in Advance I told you this morning itself what was likely to happen in the market. When I say there will be profit booking in small- and mid-cap stocks, there is no need to check any other channel because almost no small- or mid-cap stock is likely to move on that day. I understand market behaviour very quickly. The market is currently completely sideways. This means one stock goes up on one day, and another stock goes up the next day. That is why trading is almost impossible in such a market. If you buy a stock today, it may fall tomorrow, while a different stock moves up. Then that stock may also fall. This is completely normal in a sideways market. Patience Will Be Rewarded Those who understand this type of market and stay invested in good-quality stocks with patience will be rewarded when a sudden rally begins. The market has been moving sideways for the last two to three months. If you want to generate good profits, you must have the patience to handle such a market, where you may not see any returns for many days. Why Is the Indian Market Underperforming? The Indian market is not outperforming for two main reasons. 1. High Valuations: Even after nearly 1.5 years of underperformance, Indian market valuations remain expensive compared to other emerging markets. Strong SIP inflows have prevented any major market correction, keeping valuations elevated. 2. Weak Earnings Growth: The earnings growth of large-cap companies continues to remain in the single digits, which is not attractive enough for global investors. What Does the Market Want? The market wants one of two things: Attractive valuations, or Strong earnings growth. At present, the Indian market is lagging on both fronts. Why Are FIIs Buying Pharma Stocks? FIIs' favourite sectors have traditionally been IT and banking. However, earnings from both sectors have been weak. As a result, FIIs have started accumulating pharma stocks, where earnings growth is much stronger than in IT and banking. The Biggest Lesson for Investors This clearly shows that FIIs are looking for growth. They will invest only in sectors and companies where they see strong future earnings growth. That is why investors should focus on businesses with improving earnings rather than chasing short-term price movements.💥💥

Market Outlook: Why Patience Is the Key in the Current Market I Predicted Today's Market in Advance I told you this morning itself what was likely to happen in the market. When I say there will be profit booking in small- and mid-cap stocks, there is no need to check any other channel because almost no small- or mid-cap stock is likely to move on that day. I understand market behaviour very quickly. The Market Is Completely Sideways The market is currently completely sideways. This means one stock goes up on one day, and another stock goes up the next day. That is why trading is almost impossible in such a market. If you buy a stock today, it may fall tomorrow, while a different stock moves up. Then that stock may also fall. This is completely normal in a sideways market. Patience Will Be Rewarded Those who understand this type of market and stay invested in good-quality stocks with patience will be rewarded when a sudden rally begins. The market has been moving sideways for the last two to three months. If you want to generate good profits, you must have the patience to handle such a market, where you may not see any returns for many days. Why Is the Indian Market Underperforming? The Indian market is not outperforming for two main reasons. 1. High Valuations: Even after nearly 1.5 years of underperformance, Indian market valuations remain expensive compared to other emerging markets. Strong SIP inflows have prevented any major market correction, keeping valuations elevated. 2. Weak Earnings Growth: The earnings growth of large-cap companies continues to remain in the single digits, which is not attractive enough for global investors. What Does the Market Want? The market wants one of two things: Attractive valuations, or Strong earnings growth. At present, the Indian market is lagging on both fronts. Why Are FIIs Buying Pharma Stocks? FIIs' favourite sectors have traditionally been IT and banking. However, earnings from both sectors have been weak. As a result, FIIs have started accumulating pharma stocks, where earnings growth is much stronger than in IT and banking. The Biggest Lesson for Investors This clearly shows that FIIs are looking for growth. They will invest only in sectors and companies where they see strong future earnings growth. That is why investors should focus on businesses with improving earnings rather than chasing short-term price movements.

Today, the index is in the green mainly because of the relief rally in the IT sector. Otherwise, the broader market is witnessing strong profit booking. For the last two months, the market has been completely sideways. In such a sideways market, volatility tends to be very high. One day you may see a particular stock or sector outperforming, and the next day a different stock or sector takes the lead. FIIs continue to sell despite the profit booking in US AI stocks. They are still not ready to return to the Indian market because of two major concerns: high valuations in the Indian market and the lack of strong earnings growth. These two factors are preventing FIIs from increasing their exposure to Indian equities.💥

The market is under strong selling pressure, especially in small-cap and mid-cap stocks, ahead of tomorrow's US Federal Reserve policy meeting outcome. Tomorrow is a very important day for the market. The outcome of the US Federal Reserve's policy meeting will be closely watched. Many US AI stocks have been falling in anticipation of a possible interest rate hike. A large number of AI companies have borrowed heavily to fund their expansion, and the market is concerned that if the Fed raises interest rates, their borrowing costs will increase, which could put pressure on future earnings. The Fed's commentary will be equally important. Investors will closely analyse what the Fed expects for inflation, economic growth, and the future path of interest rates. Any indication of further rate hikes or a prolonged period of higher interest rates could have a significant impact on global equity markets, especially AI and technology stocks.🚀🚀

As I predicted earlier, I believe the next bull run in the Smallcap 250 index is very close. In my latest YouTube video, I explained that last week's market correction was not driven by the war, but by weak Q1 earnings from large banking stocks such as HDFC Bank and Axis Bank. Their disappointing results dragged the Nifty 50 below the 24,000 level, triggering panic selling across the Smallcap 250 index. Today, the market witnessed a strong recovery. In my view, the next leg of the rally could begin next month as the majority of companies announce their Q1 results. Right now, the market is simply waiting for earnings—not war-related news. The war-related concerns have already been priced in. In June, the war had ended, the Strait of Hormuz had reopened, and crude oil prices had fallen below USD 90. Despite these positive developments, the market underperformed. This is the lesson for those who blame war for market underperformance. This clearly shows that the market is hungry for earnings growth. Initially, IT stocks were punished because of weak growth guidance, which weighed on the indices. Last week, banking stocks came under pressure following weak Q1 earnings, pulling the Nifty 50 lower. The market is making decisions based on corporate earnings, not on the war headlines that many social media experts continue to focus on. Investors who remain patient and stay invested through this sideways phase are likely to be rewarded in the upcoming rally. This is a completely different market. It is a true stock picker's market, where companies and sectors with strong future earnings growth are expected to outperform. No growth, no returns. ✅ Today, we exited our multibagger recommendation "Atlanta Electric " with a 65% return (₹980 to ₹1,614). We will soon be adding a new high-conviction multibagger stock to our recommendation list. 💥

👉Jewellery sector stocks have been showing impressive strength over the past week. The rally is largely driven by expectations of robust demand during the upcoming festive season, a period that typically sees a sharp increase in jewellery sales. Some of the jewellery stocks showing strong relative strength today include: • Senco Gold • D P Abhushan • Thangamayil Jewellery • Tribhovandas Bhimji Zaveri (TBZ) • PN Gadgil Jewellers • BlueStone Jewellery • Sky Gold

"Stallion India," our Diwali Muhurat stock, has continued to rise steadily 🚀🚀

" Laurus labs " Posted very good Q1 result..